This website uses cookies to enhance the user experience.
H

HUBRO THERAPEUTICS AS921 833 016

Research
Limited company
Ullernchausséen 64 0379 OSLO, Norge
Services
/ Research

HUBRO THERAPEUTICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
ØA

Øyvind Kongstun Arnesen1957

Chairman of the board
ØA

Øyvind Kongstun Arnesen1957

Years since formation
6 years
since Dec 5, 2018
Type
Limited company
VAT registered
No
Number of employees
9

Ownership

Number of shares and share classes
4,135,877
1 share class
Total number of shareholders
43
38 companies, 5 persons

Financials

Annual total result 2022
-31,551,681
NOK
Total equity 2022
36,467,975
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
ØA

Øyvind Kongstun Arnesen

1957

Resigned		Managing Director/CEO-

Board

NameRoleShares
KN

Kjeld-Håkon Langeland Nilsen

1972

Board Member
5.01 %
indirectly
ØA

Øyvind Kongstun Arnesen

1957

Resigned		Chairman-
AP

Aitana Peire Morais

1977

Resigned		Board Member-
BV

Birgitte Gangmark Villmo

1985

Resigned		Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-

Top 10 individual shareholders

NameRoleShares
KA

Kjetil Myrlid Aasen

1975

-
12.37 %
indirectly
JA

Jon Amund Eriksen

1954

-
8.14 %
indirectly
KN

Kjeld-Håkon Langeland Nilsen

1972

Board Member
5.01 %
indirectly
TA

Tom Arne Thorsen

1967

-
4.99 %
indirectly
PC

Peer Christensen

1962

-
3.26 %
indirectly
SM

Svein Morten Sørensen

1956

-
1.25 %
indirectly
SO

Sofie Odfjell

2003

-
1.04 %
indirectly
EO

Elise Odfjell

2005

-
1.04 %
indirectly
Last update: Mar 2, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
I
INVESTINOR DIREKTE AS
NO0012442260
908,953
21.98 %
SU

Switzerland Ag Ubs

NO0012442260
570,514
13.79 %
J
JANDERSEN KAPITAL AS
NO0012442260
414,246
10.02 %
T
TIMMUNO AS
NO0012442260
336,831
8.14 %
SU

Switzerland Ag Ubs

NO0012442260
310,237
7.5 %
M
MYRLID AS
NO0012442260
304,406
7.36 %
R
RADFORSK INVESTERINGSSTIFTELSE
NO0012442260
245,417
5.93 %
A
ALGOT INVEST AS
NO0012442260
186,395
4.51 %
F
FARVATN VENTURE AS
NO0012442260
143,403
3.47 %
V
VIKINGEN AS
NO0012442260
134,898
3.26 %
II

Innovations Consulting L Integrated

NO0012442260
100,000
2.42 %
J
JAG HOLDING AS
NO0012442260
53,461
1.29 %
L
LØREN HOLDING AS
NO0012442260
51,706
1.25 %
B
BRØDRENE LONDON AS
NO0012442260
41,291
1 %
M
MORTEN THORSEN HOLDING AS
NO0012442260
40,552
0.98 %
O
O. G. OTTERSLAND AS
NO0012442260
39,991
0.97 %
M
MARCHMAIN AS
NO0012442260
30,158
0.73 %
V
VÅRLI AS
NO0012442260
28,680
0.69 %
K
KIRITEC AS
NO0012442260
25,484
0.62 %
E
ELAMA AS
NO0012442260
21,956
0.53 %
D
DEIGEN HOLDING AS
NO0012442260
18,375
0.44 %
L
LYBERGS ASSURANSE AS
NO0012442260
17,670
0.43 %
C
CHC INVEST AS
NO0012442260
17,596
0.43 %
P
PHILIPO AS
NO0012442260
13,638
0.33 %
AR

Anders Roald Christensen

1985

NO0012442260
10,000
0.24 %
F
FURCIFER AS
NO0012442260
10,000
0.24 %
L
Lychegården A/S
NO0012442260
7,682
0.19 %
A
ASYMMETRIC CAPITAL AS
NO0012442260
7,422
0.18 %
S
SUNWAY AS
NO0012442260
5,022
0.12 %
A
ADJUVANT GROUP HOLDING AS
NO0012442260
4,663
0.11 %
R
RINGSTIND HOLDING AS
NO0012442260
4,663
0.11 %
J
JENS CHRISTIAN RIVENES AS
NO0012442260
4,425
0.11 %
B
BKE INVEST AS
NO0012442260
4,383
0.11 %
B
BERARD HOLDING AS
NO0012442260
3,730
0.09 %
U
ULLER HOLDING AS
NO0012442260
3,535
0.09 %
V
VESTCORP AS
NO0012442260
3,151
0.08 %
A
ASTOMAN AS
NO0012442260
3,125
0.08 %
L
LOBSTER MANAGEMENT AS
NO0012442260
2,500
0.06 %
V
VIRKELYST AS
NO0012442260
2,303
0.06 %
AS

Anders Stokvold

1972

NO0012442260
1,875
0.05 %
E
ENIG AS
NO0012442260
772
0.02 %
I
IRIS CAPITAL AS
NO0012442260
384
< 0.01 %
F
FAL INVEST AS
NO0012442260
384
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year20222021
Total operating income
0
53,550
Annual Total Result
-31,551,681
-7,536,854
Total assets
83,591,652
71,599,935
Total liabilities
47,123,677
3,580,279
Total equity
36,467,975
68,019,656

P&L

Year20222021
Total operating income
0
53,550
Total operating costs
31,712,751
7,704,941
Operating result
-31,712,751
-7,651,391
Financial income/costs
161,070
114,537
Profit before tax
-31,551,681
-7,536,854
Total tax & extraordinary income/cost
0
0
Annual Total Result
-31,551,681
-7,536,854

Balance overview

Year20222021
Total fixed assets
10,070,146
0
Total current assets
73,521,506
71,599,935
Total assets
83,591,652
71,599,935
Short term debt
11,698,677
3,580,279
Long term debt
35,425,000
0
Total liabilities
47,123,677
3,580,279
Contributed capital
36,467,975
68,019,656
Retained earnings
0
0
Total equity
36,467,975
68,019,656
Total equity and liabilities
83,591,652
71,599,935

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology